Literature DB >> 3163335

TGF-beta inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events.

J C Chambard1, J Pouysségur.   

Abstract

Transforming growth factor beta (TGF-beta) was found to inhibit (IC50 = 0.1 ng/ml) alpha-thrombin or FGF-induced mitogenicity in G0-arrested Chinese hamster lung fibroblasts. Growth factor-stimulated cells became rapidly insensitive to TGF-beta addition during their progression through G0/G1 suggesting that an early step of the mitogenic response was the target of TGF-beta action. Surprisingly, none of the well characterized early mitogenic events commonly triggered by growth factors was found to be affected by TGF-beta addition. These responses included: phosphoinositide breakdown, activation of protein kinase C as determined by EGF receptor down-modulation, subsequent rises in pHi, c-fos, and c-myc mRNA levels, ribosomal protein S6 phosphorylation, the increase in RNA and protein synthesis, induction of ornithine decarboxylase. Only the induction of thymidine kinase, a marker of entry in the S phase, was found to be repressed by TGF-beta, with maximal inhibition when TGF-beta was added early in G1. These results indicate that the inhibitory action of TGF-beta does not affect the growth factors signalling pathways but touches an early event different from those so far analyzed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163335     DOI: 10.1002/jcp.1041350114

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Sensitivity of the cell cycle to TGF beta 1 does not correlate with transformation of a rat liver epithelial cell line.

Authors:  R Davies; R F Legg; G E Neal
Journal:  Cell Biol Toxicol       Date:  1990-10       Impact factor: 6.691

Review 2.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

Review 3.  Heterotopic ossification: clinical and cellular aspects.

Authors:  J R Sawyer; M A Myers; R N Rosier; J E Puzas
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

4.  Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions.

Authors:  M Moenner; E Hatzi; J Badet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

5.  Ki-67, TGF-β1, and elastin content are significantly altered in lip carcinogenesis.

Authors:  Gabriela Salvadori; Jean Nunes Dos Santos; Marco Antonio Trevizani Martins; Artur Cunha Vasconcelos; Luise Meurer; Pantelis Varvaki Rados; Vinicius Coelho Carrard; Manoela Domingues Martins
Journal:  Tumour Biol       Date:  2014-05-06

6.  Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex.

Authors:  M C Birchenall-Roberts; F W Ruscetti; J Kasper; H D Lee; R Friedman; A Geiser; M B Sporn; A B Roberts; S J Kim
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

Review 7.  Regulation of smooth muscle cell growth by endothelium-derived factors.

Authors:  T Scott-Burden; P M Vanhoutte
Journal:  Tex Heart Inst J       Date:  1994

8.  Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells.

Authors:  E Berrou; M Fontenay-Roupie; R Quarck; F R McKenzie; S Lévy-Toledano; G Tobelem; M Bryckaert
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta.

Authors:  S B Jakowlew; J E Mead; D Danielpour; J Wu; A B Roberts; N Fausto
Journal:  Cell Regul       Date:  1991-07

10.  Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.

Authors:  J Reibman; S Meixler; T C Lee; L I Gold; B N Cronstein; K A Haines; S L Kolasinski; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.